The Commissioner of Consumer Protection shall appoint a prescription drug monitoring working group for the purpose of advising the commissioner on the implementation of the electronic prescription drug monitoring program established pursuant to section 21a-254, including the adoption of regulations by the commissioner. Such advice shall include, but not be limited to, recommendations on how to effectively use the data collected pursuant to such program to detect fraud while protecting the legitimate use of controlled substances. The working group shall include, but not be limited to: (1) A physician, licensed pursuant to chapter 370, specializing in internal medicine; (2) a board certified oncologist; (3) a person licensed to perform advanced level nursing practice activities pursuant to subsection (b) of section 20-87a; (4) a representative from an acute care hospital licensed pursuant to chapter 368v; (5) a state police officer appointed in accordance with section 29-4; (6) a municipal police chief; (7) a representative from the Division of Criminal Justice; (8) a representative from a hospice licensed by the Department of Public Health or certified pursuant to 42 USC 1395x; (9) a pain management specialist, as defined in section 38a-492i; (10) a pharmacist licensed pursuant to section 20-590, 20-591 or 20-592; and (11) a representative from the Department of Mental Health and Addiction Services.
(P.A. 06-155, S. 2.)
Structure Connecticut General Statutes
Title 21a - Consumer Protection
Chapter 420b - Dependency-Producing Drugs
Section 21a-240. (Formerly Sec. 19-443). - Definitions.
Section 21a-241. (Formerly Sec. 19-449). - Prior regulations continued.
Section 21a-242. (Formerly Sec. 19-450a). - Schedules of controlled substances. Exceptions.
Section 21a-243. (Formerly Sec. 19-451). - Regulations. Schedules of controlled substances.
Section 21a-247. (Formerly Sec. 19-454). - Qualifications of applicant for license.
Section 21a-249. (Formerly Sec. 19-457). - Prescription requirements.
Section 21a-250. (Formerly Sec. 19-458). - Rights and duties of pharmacist.
Section 21a-253. - Possession of marijuana pursuant to a prescription.
Section 21a-254a. - Appointment of prescription drug monitoring working group. Membership.
Section 21a-258. (Formerly Sec. 19-465). - Exceptions concerning possession and control.
Section 21a-264. (Formerly Sec. 19-470). - Notice to licensing boards of violations by licensees.
Section 21a-266. (Formerly Sec. 19-472). - Prohibited acts.
Section 21a-272. (Formerly Sec. 19-475). - Preparations which may be sold and dispensed. Exceptions.
Section 21a-273. (Formerly Sec. 19-476). - Substances exempt under federal law.
Section 21a-274. (Formerly Sec. 19-477). - Cooperation in enforcement of law.
Section 21a-275. (Formerly Sec. 19-478). - Revocation or suspension of licenses by commissioner.
Section 21a-276. (Formerly Sec. 19-479). - Discretion of commissioner to issue warning.
Section 21a-279d. - Cannabis given by one consumer to another.
Section 21a-280. (Formerly Sec. 19-481a). - Breathing of anesthesia not violation.
Section 21a-282. (Formerly Sec. 19-482). - No prosecution where federal action has been taken.
Section 21a-283a. - Court authorized to depart from imposing mandatory minimum sentence.
Section 21a-307. (Formerly Sec. 19-504i). - Definitions re dispensing of drugs.